MAYNE PAIR MAKE DEBUT

THE carve up of Mayne Group's underperforming operations was formalised yesterday, after two spin-offs -- Symbion Health and Mayne Pharma -- debuted on the Australian Stock Exchange. The healthcare conglomerate has hived off its global pharmaceuticals business, now called Mayne Pharma, and rebranded its domestic business Symbion Health to allow the two entities to focus on their strengths. Symbion started its first day on the market at a high of $3.80 before easing back to $3.16 by market close.

Melbourne Herald Sun (http://www.heraldsun.news.com.au/common/story_page/0,5478,17321192%255E664,00.html)